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Introduction
Thrombectomy is the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusions. After a thrombectomy, iodine contrast media used during the procedure may appear as hyper-attenuating lesions, or contrast staining, in the brain ischemic territory by noncontrasted computed tomography (NCCT) scans performed after endovascular treatment at an incidence of 31.2% to 87.5%. [1] [2] [3] [4] Previous studies have suggested that hyper-attenuating lesions occur as a result of a rupture of the blood-brain barrier (BBB) by the ischemic process causing contrast media extravasation into the ischemic brain tissue. Depending on the density and severity of these hyper-attenuating lesions, it may represent a temporary contrast media enhancement, a prolonged contrast media extravasation, or different grades of hemorrhage. [5] [6] [7] Previous studies have investigated how to differentiate hyper-attenuating lesions and predict hemorrhagic transformation (HT). 1, [7] [8] [9] [10] [11] [12] [13] [14] The identification of patients who would have a higher risk of hemorrhage after thrombectomy is important to establish early preventive measures as well intensive neurologic monitoring. 13, 14 In contrast, few studies have investigated the association between hyper-attenuating lesions after thrombectomy and final brain ischemic areas. [15] [16] [17] [18] [19] Early prediction of the final ischemic stroke area may improve neurologic alertness and promote early measures for malignant infarctions. The aim of the present study was to assess correlations between hyper-attenuating lesions and final brain infarcted area using the 10 regions of the Alberta Stroke Program Early CT Score (ASPECTS). 20 
Method
We retrospectively reviewed patients treated with mechanical thrombectomy for AIS between January 2009 and February 2015. The study was approved by the ethics committee of our institution, which waived the need for written informed consent from the participants. The study protocol was in accordance with the ethical standards laid down in 1964 Declaration of Helsinki and its later amendments.
The inclusion criteria for this study were patients with acute stroke due to the occlusion of large arteries of the anterior circulation that were treated by mechanical thrombectomy. The finding of hyperattenuating lesions in NCCT scans performed within 24 hours after endovascular treatment, and the presence of late NCCT scans (until 30 days after the mechanical thrombectomy), in which the hypoattenuating lesions of the final ischemic stroke can be determined, was examined. The hyper-attenuating lesions were defined as contrast staining in the brain parenchyma. The exclusion criteria were posterior circulation strokes, patients who had not undergone NCCT scans within the first 24 hours or patients in whom NCCT scans were not performed during follow-up. We also excluded patients who presented no hyperattenuating lesions on NCCT scans after treatment. Our institutional mechanical thrombectomy protocol has been previously published. 21 Patients who were treated by mechanical thrombectomy underwent an NCCT scan immediately after the procedure and another NCCT scan between 1 to 21 days later. The NCCT images were evaluated at 5-mm-axial thickness and by using the window for CT with a width and center level of 50 and 30 Hounsfield units (HU), respectively. The NCCT scans were evaluated by two independent neuroradiologists, and a third neurovascular expert examined the discordant cases.
On NCCT scans immediately post-treatment, each region of the ASPECTS was analyzed independently, and if it had evidence of a hyper-attenuating lesion, the region was considered affected. A positive correlation was observed when a hyper-attenuating lesion of an area of the ASPECTS became hypo-attenuating on the NCCT scan during follow-up, while a negative correlation was observed if the hyper-attenuating lesion did not become a hypo-attenuating area on the NCCT scan during follow-up. The correlations of initial hyper-attenuating lesions and final hypoattenuating lesions of each of the 10 areas of the ASPECTS were measured by means of sensitivity (S), specificity (Sp), positive predictive values (PPV), negative predictive values (NPV) and accuracies (A).
The hyper-attenuating lesions that remained in the NCCT scan 24 hours after treatment were considered HT, and they were categorized according to the European Cooperative Acute Stroke Study 2 (ECASS-2) classification in hemorrhagic infarct (HI type 1 or 2) or parenchymal hemorrhage (PH type 1 or 2). 22 
Statistical analysis
Statistical analysis was performed using nonparametric Mann-Whitney U for ordinal variables and Spearman's correlation to compare continuous variables with ASPECTS in NCCT scans with hyper-attenuating lesions. The S, Sp, PPV, NPV and A values were determined for each region of ASPECTS. We considered percentage values ! 80% as being high and significant values. A p value <0.05 was considered to be statistically significant. An independent statistician performed data analysis using both SPSS version 20.0 (SPSS Inc, Chicago, IL, USA) and SAS statistical software, version 9.0 (SAS Institute Inc; Cary, NC, USA).
Results
A total of 123 patients underwent mechanical thrombectomy during the study period, and 52 patients, 42.2%, were excluded. Among the 52 excluded patients, 22 patients, 42.3%, had no contrast enhancement on NCCT scans, 12 patients, 23%, presented with stroke of the posterior circulation, and 18, 34.6%, did not have NCCT scans after treatment. Eleven did not have NCCT scans because of the clinical instability of the patients, caused by cardiac, pulmonary or infection-associated conditions, while seven patients died. The remaining 71, 57.7%, patients were included. The baseline characteristics of the patients are summarized in Table 1 . The time between obtaining the NCCT scan after endovascular treatment had an average of 3.66 (range 0.5-20 hours AE 3.899) hours after the procedure, and 81.7% were carried out within four hours.
The mean accuracy of regions of ASPECTS to predict the final ischemic area was 78%. The accuracy was high for the lenticular nucleus, 91%, and the internal capsule, 90%, which also showed high sensitivities, 96.9% and 87.5%, respectively. In general, the accuracy of the deep regions of the ASPECTS-grouped caudate, lentiform, internal capsule and insular ribbon, was higher than the accuracy of the grouped cortical regions (82.7 vs. 74.8). Table 2 shows the values found for each region of the ASPECTS as well as the grouped data of the deep and superficial parenchyma. Regarding the incidence of HT after endovascular treatment, 7% of patients had symptomatic HT (PH2), 46.5% had a non-symptomatic hemorrhage (HI1, HI2 or PH1), and 46.5% had no hemorrhages. Among 71 patients included, 49.3% received intravenous tissue plasminogen activator (tPA) before thrombectomy.
Discussion
Mechanical thrombectomy improves neurologic outcomes of patients presenting with acute large vessel occlusions of the anterior circulation. However, some of these patients, notably those presenting with poor collaterals, may develop large brain infarctions despite an early and successfully recanalization obtained by thrombectomy. The early identification of the extension of the ischemic lesion may improve therapeutic planning and prognostic assessment. We used the individual regions of ASPECTS to assess which hyper-attenuating lesions would become a definitive infarction during follow-up. We found that the individual regions of ASPECTS had an overall mean test accuracy of 78% to predict the evolution of the hyper-attenuating lesions to definitive brain infarction, and this accuracy was higher for the deep regions of ASPECTS compared to the superficial regions ( Table 2 ).
The hyper-attenuating lesions on brain CT scans after acute strokes have been investigated. A mechanism was proposed to explain the occurrence of hyper-attenuating lesions in which damage in the BBB by the ischemic process allows the output of contrast and blood elements from the blood vessels to the brain parenchyma. 23 Ischemia leads to the depletion of oxygen, glucose, lactic acidosis, altered cell structure, and release of pro-inflammatory factors, oxidizing agents and proteolytic enzymes that ultimately cause cellular damage and rupture the BBB and basal lamina. The structures that form the BBB consist of neurons, endothelium, astrocytes, pericytes, and extravascular matrix. 5 A BBB rupture can be analyzed by contrast stasis in the CT scan by a hyperintense acute reperfusion marker (HARM) on the brain magnetic resonance imaging (MRI) 24 and on tomography perfusion imaging. 25 However, the association between the contrast enhancement of the brain on the NCCT scans after mechanical thrombectomy and the final infarcted brain area was poorly investigated. [17] [18] [19] One study examined three cases in which there was a good correlation between contrast uptake and final stroke, 15 while Ghobrial et al. found a sensitivity of 82% and specificity of 0% in the evaluation of 18 patients with a PPV of 100%, comparing post-treatment CT scans with late brain MRIs. 16 The dual-energy CT technique had been demonstrated as a tool capable of differentiating brain ischemia, contrast extravasation, and HT in hyper-attenuation in the CT scan. 26 In our study, we used the 10 regions of ASPECTS individually to standardize the evaluation of CT scans. The hyper-attenuating lesions of each of the 10 regions of ASPECTS in the NCCT scan after procedures were assessed in late NCCT scans. The hyperdense lesions that disappeared or had a clearing after 24 hours were not considered hemorrhages. When a hyperdense lesion cleared and become hypo-attenuating, this lesion was considered a definitive brain infarction. On the other hand, a hyperdense lesion that cleared sometimes did not evolve to ischemic areas. In these settings, hyperdense lesions were considered to be saved penumbral areas. When a hyper-attenuating lesion did not clear in 24 hours after treatment, this lesion was considered to be an HT.
We used the ASPECTS regions as a methodological tool because this score is a simple, systematic, reproducible, and widely used method to quantify the location of a brain infarction in the middle cerebral artery (MCA) territory and correlates with the National Institute of Health Stroke Scale (NIHSS) examination and neurological prognosis. 27, 28 We found that the individual regions of ASPECTS had an overall mean test accuracy of 78% in predicting the evolution of the hyper-attenuating lesions to definitive brain infarction. The association between hyper-attenuating lesions and definitive brain ischemic areas in the cortex was lower compared to deep brain structures. This may be explained by the presence of more collateral circulation in the superficial cortex compared to the deep structures of the brain. The leptomeningeal collateral circulation most likely kept the superficial cortical tissue viable longer, and some penumbral ischemic areas could cause temporary hyper-attenuating lesions that would not result in definitive infarctions. On the other hand, the deep structures had a higher conversion rate of hyper-attenuating lesions to definitive infarctions. This finding may be explained by the lower contribution of collaterals to deep brain structures, which may have small, or even short duration, penumbral areas compared to cortical areas. However, although it is considered as a deep structure, the head of the caudate nucleus presented similar results to the superficial structures, which can be explained by nutrition from the anterior cerebral artery. 29 In this study the rate of symptomatic HT (PH2) was similar to that reported in previous studies. 30, 31 In these cases, we were able to define the area of final ischemia even after HT, later assessing the hypo-attenuating extent. In most cases, HT was of small spots in the area of hypo-attenuation, which did not affect the evaluation. In cases of higher volume bleeding, we evaluated later CT scans in which the hemorrhage was already at an advanced stage of absorption and it was possible to define the final hypo-attenuation.
The limitations of the study were the small sample size and the retrospective design. A high number of patients assessed for eligibility, 18 patients (34.6%) were excluded from the study because they did not have NCCT scans within 24 hours after endovascular treatment, which may result in selection bias. We used the ASPECTS regions to assess ischemic areas instead of performing more accurate brain volumetric measurements. We did not differentiate hyper-attenuating lesions according to the grade of density. However, despite the fact that all post-treatment NCCT scans were performed within the first 24 hours, those NCCT scans performed earlier after treatment may have potentially presented more pronounced contrast enhancement than NCCT scans performed later, which could lead to significant measurement bias.
Conclusions
Hyper-attenuating lesions on head NCCT scans performed after endovascular treatment for AIS may predict final brain infarcted areas. The prediction appears to be higher in the deep brain regions compared with the cortical regions.
